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Antibiotics are nowadays used and abused worldwide in common veterinary practice to treat diseases, prevent infections, and
promote animal’s growth. Drug resistance occurrence is a relevant phenomenon that can inactivate the antibiotic. Moreover,
antibiotics used for animals are also found in milk and it poses serious health risks to humans. Another negative effect is related
to milk processors since antibiotics cause detrimental effects on cheese and yogurt starter bacteria. Given its consumption as both
beverage and derivatives, milk is one of the most regulated products in food industry. Nowadays several commercial tests are
available to investigate antibiotics in milk, but they generally provide a qualitative result, require bulky procedure, and are time
consuming. In this paper, we investigate the use of a chromogenic cephalosporin to quantify the concentration of cloxacillin—a
𝛽-lactam difficult to be detected by using “cowside” screenings which is the drug of choice in the method of mastitis control. The
proposed measurement method and prototype have been demonstrated to be able to detect cloxacillin in milk at concentrations
lower than theMRL set by the EuropeanCommission.Moreover, they are also able to detect the illegal practice of using 𝛽-lactamase
to degrade 𝛽-lactams in milk.
1. Introduction
According to World Health Organization, in 2010, 600 mil-
lion people suffered foodborne illnesses and 420,000 died [1].
As a result, there is a continuing search for newmeasurement
techniques able to investigate food quality ranging from
staple foods such as cereals and cereal products [2–4] tomore
niche products such as wines [5, 6].
Given its consumption as both beverage and derivatives
such as cheeses, butter, and yogurt, milk is one of the most
regulated products in food industry.
Nowadays almost all livestock receive medication during
their lives and antibiotic residues in milk are of great concern
to consumers, regulatory agencies, dairy farmers, and milk
processors. Indeed, antibiotic residues in milk can [7] (i)
seriously spread drug-resistant microorganisms, (ii) cause
human health problems such as allergic reaction and imbal-
ance of intestinal microflora, and (iii) badly affect cheese
and yogurt starter bacteria. Therefore, there is great interest
in methods capable of a fast, reliable, and multiantibiotic
sensing.
Among veterinary antibiotics, 𝛽-lactams are one of the
most widely used drug classes for the treatment of animals
in Europe [8] and all over the world; hence, maximal residue
limits (MRLs) have been set by major regulatory agencies,
for example, the European Commission Regulation 2377/90.
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Thus, in the last decades, many measurement methods have
been developed to detect 𝛽-lactams in food and feed samples
[8, 9].
The oldest and simpler methods are microbial inhibition
tests consisting in adding milk samples to organisms suscep-
tible to the target antibiotics, incubating them, and finally
monitoring eventual fails to grow.
Then, many other semiquantitative and quantitative
methods such as enzymatic colorimetric assays, microbial
receptor assays, receptor binding assays, enzymatic assays,
chromatographic analysis, and immunoassays have been
developed [7–9]. However, suspected samples detected by
qualitative method generally requires being quantified and
confirmed by using techniques such as high pressure liquid
chromatography (HPLC) and mass spectrometry (MS) [8, 9]
which are expensive and impractical for field testing.
Also commercial screening tests such as Charm Farm
Cowside by Charm Sciences Inc. (USA), IDEXX SNAP
by Thermo Fisher Scientific (USA), Delvotest SP by DSM
(Holland), and BetaXpress, TwinsensorBT, and TriSensor by
Unisensor Diagnostic Engineering (Belgium) are available to
investigate𝛽-lactams presence inmilk samples. Nevertheless,
they provide qualitative results only, require bulky procedure,
and are time consuming. As an example, the TwinsensorBT
requires the following: (i) add 200 𝜇l of milk into one reagent
microwell and mix, (ii) incubate it for 3 minutes at 40∘C,
(iii) dip one Dipstick into each microwell, (iv) continue
incubating for 3min at 40∘C, and, finally, (v) read the color
intensities.
Driven by the continued search for new measurement
techniques, several other methods have been proposed (i.e.,
[10–15]). Nonetheless, most of such methods are laborious
and time consuming and require modifications of the anti-
body used in the assay.
Moreover, sometimes dairy industries illegally add 𝛽-
lactamase in milk to degrade 𝛽-lactams antibiotics [14, 16,
17]. Such illegal practice may reduce 𝛽-lactams concen-
tration, but it exposes consumers to risks to the health
since the safety of 𝛽-lactamase has not been fully evaluated
[17].
In this paper, we propose a measurement method based
on a relatively low cost chromogenic 𝛽-lactamases substrate
(CENTA) and we developed and tested a simple and inex-
pensive prototype measuring instrument potentially able to
detect and quantify 𝛽-lactam antibiotics in milk. In partic-
ular, this preliminary study has been focused on the possi-
bility of measuring cloxacillin. Among 𝛽-lactam antibiotics,
cloxacillin has been chosen since (i) it is from a long time the
drug of choice in the method of mastitis control [7, 18], (ii) it
is difficult to be detected by using multiresidue tests [7], and
(iii) its detection limit for some of the most commonly used
“cowside” screening tests is above the legalMRLs, resulting in
false negatives [7].
Moreover, as it will be discussed in detail, the developed
measurement method and system are also intrinsically sensi-
tive to the eventual presence of 𝛽-lactamase illegally added to
the milk.
Since cattle produce about 85% of world milk production
(followed by buffaloes with ≈11%, goats with ≈2%, and sheep
with ≈1%) [19], such preliminary study has been focused on
cow’s milk.
In the following, Section 2.1 briefly reviews competitive
assays at the basis of the proposed measurement method;
such method is then described in Section 2.2.
The developed prototype measuring system (proof of
concept) and measurement procedure are described in Sec-
tion 2.3 and the test performed to verify the method and
to calibrate and test the measuring system is reported in
Section 2.4.
The obtained results are reported and discussed in Sec-
tion 3, and conclusions are drawn in Section 4.
Finally, detailed descriptions of both the performed data
analysis and 𝛽-lactamases detection are reported in Appen-
dices A and B, respectively.
2. Materials and Methods
2.1. Introduction to Two-Step Competitive Assays and Enzyme
Kinetic. As described in detail in Section 2.2, the proposed
measurement method is a two-step competitive assay.
Differing from direct assays (noncompetitive), in com-
petitive assays, the concentration/presence of the analyte of
interest—the measurand—is measured by adding a known
amount of another analyte, competitive with the analyte of
interest, then exploiting its ability to compete with analyte
added to the sample.
Obviously, the concentration of the competitive analyte
added to the solution has to be properly designed to match
the required measuring interval for the concentration of the
analyte of interest [20, 21].
In particular, given the use of a two-step competitive
format, the reagent concentration has to be in excess in
comparison to the concentration of the measurand.
Then, as it will be described in Section 2.2, the “substrate”
is first added to the specimen containing the measurand and,
in the second step, the enzyme competitive with the analyte
of interest—𝛽-lactams antibiotics—is added.
For a fully competitive enzyme reaction, the time evolu-
tion of the concentration of the enzyme-substrate intermedi-
ate complex [𝐸𝑆](𝑡) is [22]
[𝐸𝑆] (𝑡) = [𝐸0] [𝑆]𝐾𝑆 ⋅ (1 + [𝐼] /𝐾𝐼) + [𝑆]
⋅ {1 − 𝑒−[𝐾𝑆(1+[𝐼]/𝐾1)+[𝑆0]]⋅𝑘1 ⋅𝑡} ,
(1)
where 𝑡 is the time, [𝐸0] is the free enzyme concentration at
time 𝑡 = 0, [𝑆](𝑡) is the substrate concentration, [𝑆0] is the
substrate concentration at time 𝑡 = 0, [𝐼](𝑡) is the inhibitor
concentration, and,𝐾𝑆, 𝐾1, and 𝑘1 are constants.
2.2. The Proposed Measurement Method. The proposed mea-
surement method is based on a modification of the competi-
tive binding assay reported by Bebrone et al. [23].
In particular, the method is based on the use of
CENTA—a commercially available cephalosporin that can be
prepared from the cephalothin [24]—and the 𝛽-lactamase
enzyme (AmpC). Indeed, CENTA is not an antibiotic itself;
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Figure 1: Schematic representation of the proposed measurement
method. If no antibiotic is present, all the AmpC is linked to the
CENTA (1), thus hydrolyzing 𝛽-lactam rings. However, if some
𝛽-lactam antibiotic inhibitor of AmpC is present, some AmpC will
link to it, thus reducing the hydrolysis of 𝛽-lactam rings, hence
reducing the overall variation of the absorption spectra of the
CENTA.
therefore, it can be useful for analytical purpose when the
𝛽-lactam antibiotics have to be detected in a sample matrix
by using a competitive assay.
It is known that CENTA is readily hydrolyzed by
𝛽-lactamases (AmpC); thus, according to Jones et al. [25],
CENTA reactionwith𝛽-lactamase gives rise to changes in the
absorption spectra of theCENTAmoving its peakwavelength
from about 340 nm to about 405 nm concomitantly with
hydrolysis of the 𝛽-lactam ring.
According to the results of the inhibition tests reported
in Section 3, cloxacillin and other 𝛽-lactams antibiotics
are inhibitors of 𝛽-lactamase (AmpC) and reduce their
effectiveness. The strength of such inhibition is described
by the inhibition constant (𝐾𝑖) whose value depends on
the specific antibiotic and substrate. Therefore, the proposed
measurement method is based on the hypothesis that if some
𝛽-lactam antibiotic inhibitor of AmpC is present in the milk
sample, it will compete with the CENTA for the active sites of
the 𝛽-lactamase enzymes (AmpC). As a result, we propose
a competitive binding assay in two steps in which known
amounts of CENTA ([𝑆0] in (1)) and AmpC ([𝐸0] in (1)) are
subsequently added to the sample under test, thus analyzing
the variation in the absorption spectrum of the sample itself.
According to (1), if no 𝛽-lactams antibiotics are present in
the milk sample ([𝐼] = 0), a fixed and known variation in the
absorption spectrum is expected. However, as schematically
shown in Figure 1, in the presence of inhibitors, the AmpC
is expected to produce a reduced variation of the CENTA
spectrum. Therefore, once the concentration of the AmpC
([𝐸0]) is fixed, the higher the variation of the absorption
spectrum of the CENTA, the lower the concentration of the
inhibitor ([𝐼] in (1)) in the tested milk sample.
2.3. The Developed Prototype Measuring System and Measure-
ment Procedure. According to the enzymes kinetic described
in Sections 2.1 and 2.2, the developed measuring system
analyzes the time evolution of the absorbance of the sample as
a consequence of the additions of known amounts of CENTA
and AmpC.
Control
electronics
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electronics
LED PD
Cuvette
ADC
PC
USB
I/O Arduino
UNO
V０＄(t)
Figure 2: Block diagram of the developed prototype measuring
system.
Table 1: Timing of the proposed measurement procedure. 𝑛 is the
sample index (see Figure 3).
Interval Duration
[1, 𝑛1] 50 s
[𝑛1, 𝑛2] Δ 𝑡 = 15 s
[𝑛2, 𝑛3] 225 s
[𝑛3, 𝑛4] Δ 𝑡 = 15 s
[𝑛4, 𝑛TOT] 280 s
In particular, as shown in Figure 2 during measurement
the milk sample is placed in a cuvette with an optical path
of 1mm; hence, it is illuminated by using a LED with a
peak wavelength of 405 nm (model, LED-405-33V, Roith-
ner LaserTechnik—nominal full width at half maximum at
20mAequal to 15 nm) and the absorbance at suchwavelength
is estimated by using the photodiode PD (model HFD 1100,
EG&G).
The system is then controlled by using an Arduino UNO
board which (i) switches on/off the LED, (ii) analyzes the sig-
nal provided by the photodiode, and (iii) communicates with
the PC through a USB port. Indeed, the control electronic is
basically composed of a constant current generator, whereas
the front-end electronic is composed of a transimpedance
amplifier and an instrumentation amplifier. The output volt-
age𝑉PD(𝑡) of the front-end electronic is digitalized by using a
10-bit ADC included in the Arduino UNO board.
The so acquired data are transmitted to the PC and
elaborated according to themeasurementmodel described in
the following.
In particular, the system analyzes the acquired 𝑉PD(𝑛)
digitized samples of 𝑉PD(𝑡) signal according to the timing
diagram shown in Figure 3 and described in Table 1. Sup-
posing that the measurement starts at time 𝑡 = 𝑡0 and then
adding the CENTA and the AmpC at times 𝑡CENTA and 𝑡AmpC,
respectively,𝑉Milk and𝑉CENTA values are themean and𝑉PD(𝑖)
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Figure 3: Timing diagram of the developed measurement proce-
dure. Supposing that themeasurement starts at time 𝑡 = 𝑡0 and stops
at time 𝑡 = 𝑡Meas, the CENTA and the AmpCwere addedmanually to
the sample under test at times 𝑡CENTA and 𝑡AmpC by Gilson pipettes.Δ 𝑡 is time intervals after addition of CENTA and AmpC. 𝑛 is the
sample index.
values recorded during the time intervals [𝑡0, 𝑡CENTA) and[𝑡CENTA + Δ 𝑡, 𝑡AmpC), respectively:
𝑉Milk = 1𝑛Milk ⋅
𝑛1−1∑
𝑛=1
𝑉PD (𝑛)
𝑉CENTA = 1𝑛CENTA ⋅
𝑛3−1∑
𝑛=𝑛2
𝑉PD (𝑛) .
(2)
Then, as described in Appendix A, the antibiotic concentra-
tion [𝐶𝛽] has been estimated by analyzing the final or steady-
state pseudo-absorbance Γ∞:
[𝐶𝛽] = 𝑎Γ∞ − 𝑏, (3)
where 𝑎 and 𝑏 are the constants of the calibration function
and, as described in Appendix A, Γ∞ was estimated by
interpolating the Γ function defined as
Γ (𝑛 − 𝑛4) | 𝑛 ∈ [𝑛4, 𝑛TOT] = log10𝑉CENTA − 𝑉Dark𝑉PD (𝑛) − 𝑉Dark , (4)
with the function
Γ (𝑖) = Γ∞ − 𝛽 ⋅ 𝑒−𝛼(𝑖+𝑖𝑥), (5)
where 𝑖was the independent variable, Γ(𝑖)was the dependent
variable, and Γ∞, 𝛽, 𝛼, and 𝑖𝑥 were the parameters.
As described in Appendix A, 𝑉Dark value in (4) is the
mean 𝑉PD value recorded before starting the measurement
and replacing the cuvette with a beamblocker. Such valuewas
exploited to compensate offsets.
Similarly,𝑉Milk value defined in (2) was exploited to check
for anomalies due, as an example, to variation in the power
emitted by the LED and/or unnatural absorbance of the
milk sample. Moreover, as described in Appendix B,𝑉Milk
also allows potentially detecting the illegal practice of adding
𝛽-lactamase to milk.
A picture of the developed prototypemeasuring system is
shown in Figure 4.
Cuvette
holder
PD
LED ArduinoUNO
Figure 4: Picture of the developed prototype measuring system.
In the figure, it is possible to see the LED, the photodiode PD, the
cuvette holder, and theArduinoUNOboard.Duringmeasurements,
the system was enclosed in a plastic box to minimize the effects due
to environmental lighting and stray-light.
2.4. The Performed Experimental Activities. As previously
introduced, the performed experimental activities have been
aimed at investigating both the feasibility of the proposed
measurement method and the performance of the developed
prototype measuring system.
Thus, four different activities were performed: (i) inhibi-
tion test, (ii) feasibility verification, (iii) system calibration,
and (iv) system verification.
All experiments have been performed at room temper-
ature and without controlling/modifying the temperature of
the milk samples.
All the used milk was whole-milk for human consump-
tion and it was bought on themarket; thus, it was supposed to
be free of antibiotics. Measurements have been then obtained
without diluting the milk samples.
Finally, an Escherichia coli K12 AmpC 𝛽-lactamase [26]
was used for all experimental activities. The concentration
of AmpC was determined spectrophotometrically in con-
centrated stock solutions made from lyophilized powder
and subsequently diluted; this enzyme had been previously
expressed and purified, as described by Powers et al. [27].
2.4.1. Inhibition Test. Since the basic idea of the proposed
method is that 𝛽-lactams could behave as inhibitors of
AmpC-type 𝛽-lactamases, the strength of such inhibition has
been evaluated in terms of inhibition constant (𝐾𝑖) towards
AmpC 𝛽-lactamase in buffer and CENTA substrate. In
particular, besides cloxacillin, the test investigated cefalexin,
cefoperazone, cefalonium, oxacillin, and dicloxacillin.
2.4.2. Feasibility Verification. Feasibility tests have been
aimed at investigating the stability of CENTA and AmpC
in the milk matrix. Indeed, in case of reagents instability,
the overall signal would be decreased for the concentration
decrease and not for the enzymatic reaction.
All the feasibility tests have been performed by using
an UV/Vis Spectrophotometers (Lambda 25, Perkin Elmer—
scan-rate set equal to 60 nm/min) and a glass cuvette with
an optical path of 1mm. Then, all measurements have been
performed at room temperature and without incubating
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Table 2: Performed feasibility tests and relative component concen-
trations. ∗Buffer (K𝑥H𝑦PO4, pH 7.00) volume added to reach the
final cuvette volume of 300𝜇l. ∗∗Milk volume added to reach the
final cuvette volume of 300𝜇l.
Component Stock Cuvette
concentration concentration
FT1, buffer
Buffer∗
CENTA 5mM 240 𝜇M
AmpC 13.85 𝜇M 130 nM
FT2, milk
Milk∗∗
CENTA 5mM 240 𝜇M
AmpC 13.85 𝜇M 130 nM
FT3, antibiotic
Milk∗∗
CENTA 5mM 240 𝜇M
AmpC 13.85 𝜇M 130 nM
Cloxacillin 0.5 𝜇M 5nM
10 nM
the samples. As resumed in Table 2, the feasibility test “1”
(FT1) has been aimed at acquiring the “standard” spectra
of CENTA, thus firstly measuring the absorbance of buffer
and then the absorbance of buffer and CENTA and finally
measuring time evolution of the absorbance of the sample
composed of buffer, CENTA, and AmpC after the addition
of AmpC (4 spectra, 𝑡 ∈ [0, 25] minutes). The second
feasibility test (FT2) has been aimed at investigating the
effect of the milk on the absorption spectra of the CENTA.
Hence, FT2 has been performed by firstly measuring the
absorbance of the milk, then obtaining the absorbance by
adding CENTA, and finally measuring the time evolution
of absorbance resulting from the addition of the AmpC
(7 spectra, 𝑡 ∈ [0, 25] minutes). The third feasibility test
(FT3) has been aimed at investigating the effects of the
competition between𝛽-lactamantibiotics andCENTAon the
optical absorbance of milk samples. Therefore, as reported in
Table 2, the test FT3 investigated the spectra obtained from
4 samples: (i) milk (zero concentration of antibiotic), (ii)
milk (zero concentration of antibiotic), CENTA, and AmpC,
(iii) milk and antibiotic (cloxacillin, concentration 5 nM),
CENTA,and AmpC, and (iv) milk and antibiotic (cloxacillin,
concentration 10 nM), CENTA, and AmpC.
Note that themaximal residue limit (MRL) defined by the
European Medicines Agency for cloxacillin in milk is about
70 nM [7]; therefore, about an order of magnitude is greater
than the selected concentration of cloxacillin in our sample
(see Table 2) (cloxacillin molecular weight is 435.88 g/mol).
As a result, the FT3 tests were aimed also at a rough estimate
of the potential “detection limit.”
2.4.3. Calibration. Calibration activities have been aimed at
investigating the relation between the antibiotic concentra-
tion ([𝐶𝛽]) and the pseudo-absorbance Γ∞. In particular, as
reported in Table 3, the calibration of the measuring system
Table 3: Nominal concentrations of the standards realized for cal-
ibration and verification. ∗Milk volume 80 𝜇l. ∗∗Buffer (K𝑥H𝑦PO4,
pH 7.00) volume added to reach the final cuvette volume of 800 𝜇l.
Component Stock Cuvette
concentration concentration
Milk∗
Buffer∗∗
CENTA 8mM 261 𝜇M
AmpC 13.85 𝜇M 165 nM
Cloxacillin 50 𝜇M
35 nM
70 nM
105 nM
140 nM
280 nM
420 nM
560 nM
Table 4: Results of the inhibition test: inhibition constant (𝐾𝑖)
of 6 𝛽-lactam antibiotics towards AmpC 𝛽-lactamase in CENTA
substrate.
Antibiotic 𝐾𝑖
Dicloxacillin sodium salt hydrate 0.85 ± 20%nM
Cloxacillin sodium monohydrate 1.37 ± 20%nM
Oxacillin sodium monohydrate 3.73 ± 20%nM
Cefalexin 17.1 ± 20% 𝜇M
Cefalonium hydrate 82.6 ± 20% 𝜇M
Cefoperazone dehydrate 166 ± 20% 𝜇M
had been performed by realizing 8 measurement standards
based on milk and antibiotic at known concentrations.
Then, each standard was analyzed according to the
measurement procedure described in Section 2.3.
2.4.4. Verification. Verification has been performed by ana-
lyzing two (nominally equal) sets of milk samples with
known antibiotic concentration, thus comparing the known
concentration with results provided by the calibrated system.
The composition of the used milk samples is reported in
Table 3.
3. Results and Discussion
3.1. Inhibition Test. Inhibition test is resumed in Table 4.
According to the reported results, the best inhibitors and thus
the easier detectable antibiotics are dicloxacillin, cloxacillin,
and oxacillin.
3.2. Feasibility Verification. The results of feasibility tests are
shown in Figures 5–8.
As expected and shown in Figure 5, the CENTA spectrum
presents an absorption peak at 345 nm. In the presence of the
AmpC, the CENTA reacts with the AmpC active site and the
absorption peak is shifted to 405 nm.
As shown in Figure 6, the presence of milk predictably
modifies the absorption spectra with respect to the spectra
6 Journal of Sensors
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Figure 5: Absorbance curves of the buffer solution (󳶋), buffer
solution and CENTA (I), and buffer solution, CENTA, and AmpC
at consecutive time intervals (curves 󳵻, +, ◻, ⬦) (Test PT1; see
Table 2).
2.5
3
3.5
4
Ab
so
rb
an
ce
 (O
D
)
400 450350
 (nm)
Figure 6: Absorbance curves of milk (󳶋), milk and CENTA (I),
and milk, CENTA, and AmpC at consecutive time intervals (curves
󳵻, ⊳, +, ⊲, ◻, ×, ⬦) (Test PT2; see Table 2).
recorded in buffer solution (mainly the signal to noise
ratio). Nevertheless, the AmpC is still able to modify the
spectra. Note that the spikes in Figure 6 at about 380 nm
are reasonably measurement artifacts due to the lamp change
performed by the spectrometer at such wavelength.
Finally, the settled absorbance spectra obtained by sam-
ples with andwithout antibiotics (FT3) are shown in Figure 7.
As expected, the antibiotic competes with the CENTA for the
AmpC protein active site; thus, the same amount of AmpC
gives rise to a reduced variation of the absorption spectrum
(see Figure 1). Such reduction in the effect of AmpC is visible
also in Figure 8 where the time evolution of the samples
absorbance at 405 nm is shown. Once again, the spikes at
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Figure 7: Absorbance settled curves of milk (󳶋), milk and CENTA
(I), milk, CENTA, and AmpC (󳵻), milk, CENTA, AmpC, and
antibiotic (5 nM) (+), and milk, CENTA, AmpC, and antibiotic
(10 nM) (◻) (PT3; see Table 2).
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Figure 8: Time evolution of the absorbance recorded at 405 nm for
the samples composed of milk, CENTA, and AmpC. In particular,
(󳶋) is the absorbance recorded without antibiotic, (+) is the
absorbance recorded with antibiotic concentration equal to 5 nM,
and (◻) is the absorbance recorded with antibiotic concentration
equal to 10 nM (PT3, see Table 2).The horizontal line (—) represents
the absorbance recorder at 405 nm at the beginning of the test for a
sample composed of milk and CENTA with CENTA concentration
equal to 240 𝜇M.
about 380 nm in Figure 7 are reasonably measurement arti-
facts due to the lamp change performed by the spectrometer
at such wavelength.
3.3. Calibration. Calibration has been performed according
to the procedure described in Section 2.4. An example
of 𝑉PD(𝑛) signal recorded using the developed measuring
system is shown Figure 9.The results obtained by the analysis
of the standards described in Table 3 are shown in Figure 10.
The calibration function has been obtained by least square
fitting.
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Figure 9: Example of 𝑉PD(𝑛) signal recorded using the developed
prototype measuring system. The colored rectangles in the back-
ground of the figure refer to the timing diagram shown in Figure 3.
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Figure 10: Γ∞ values (⬦) obtained from the analysis of the standards
reported in Table 3 and calibration function (green line). The
constants of the calibration function are 𝑎 = 99.46 (nM) and
𝑏 = 95.27 (nM) (Pearson coefficient of the fitting 𝑅2 = 0.981).
The horizontal line (red line) represents the maximal residue limit
(MRL) defined by the European Medicines Agency for cloxacillin.
3.4. Verification. As described in Section 2.3, verification has
been performed by analyzing two sets of milk samples with
known antibiotic concentration, thus comparing the known
concentration with results provided by the calibrated system.
The obtained results are shown in Figure 11 and the absolute
values of the percentage errors are shown in Figure 12.
4. Conclusions
In this paper, we propose a measurement method and we
developed and test a “proof of concept” measuring system
that have been demonstrated to be able to detect cloxacillin
in milk at concentrations lower than the maximal residue
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Figure 11: Comparison between the nominal antibiotic concen-
tration “Nominal [𝐶𝛽]” and the concentrations estimated by the
calibrated system “Calculated [𝐶𝛽]” for the two sets of samples (⬦
and ◻). The diagonal line (red in color version) is the bisector of the
first quadrant.
limit (MRL) set by the European Commission. Furthermore,
according to the results of the inhibition test reported in
Section 3, the method could be suitable for the detection of
other 𝛽-lactam antibiotics. However, at the current stage, the
method can be used only to verify and quantify the concen-
tration of cloxacillin and the presence of other antibiotics and
inhibitors of AmpC can lead to measurement artifacts. Thus,
it could be useful for both cattle breeders who want to rapidly
test the quality of the milk of animals that have been treated
with cloxacillin and inspectors (veterinaries, regulatory agen-
cies, and milk processors) who want to test quickly and with
high resolution the presence and concentration of cloxacillin
in the milk produced by animals suspected of being treated
with such antibiotic, for example, animals suffering mastitis.
Moreover, as discussed in Section 3.3 and Appendix B,
the developed measurement method and system are also
intrinsically sensitive to the eventual presence of 𝛽-lactamase
illegally added to the milk to set to zero the 𝛽-lactams
concentration. Therefore, they are potentially able to detect
both 𝛽-lactam antibiotics and 𝛽-lactamase enzyme (AmpC)
illegally added to milk. Indeed, as discussed in Appendix A
and shown in Figure 7, anAmpC (Escherichia coli K12AmpC
𝛽-lactamase) concentration equal to some 𝜇M can be easily
detected.
CENTA, the used substrate, is not an expensive cepha-
losporin that can be prepared from the cephalothin [24]. Also
the proposed measuring system is simple, inexpensive, and
easy to use and transport to the field.
Much more testing is required and at the present time,
there is no guarantee that this method could be applied for
the detection of any other 𝛽-lactam antibiotics. Furthermore,
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Figure 12: Absolute value of the percentage errors for the two sets
of samples (⬦ and ◻).
the applicability of the method on different milk sample
matrices (e.g., goat’s and sheep’s milk) has not been verified.
Moreover, the measure of absorbance around 2.5 and 3.5 is
difficult considering the turbidity ofmilk (as an example, con-
sider the variation of the spectra from Figure 5—buffer—to
Figure 6—milk). However, the reported results suggest that
the proposed measurement method and measuring system
may be able to provide a quantitative measure of 𝛽-lactam
antibiotics concentration in milk.
As shown in Figures 7 and 8, although absorbance
variation is very small and the values are very high, the
proposedmeasurementmethod is substantially able to detect
cloxacillin at concentration at about 5 nM. Indeed, according
to (3) and Figure 10, the method is very sensitive at low
concentration.
The developed prototype measuring system has been
tested and demonstrated at concentration as low as 35 nM
(half the MRL concentration set by the European Commis-
sion).
The performance of the measuring system can be proba-
bly further improved by (i) increasing the signal to noise ratio
of the block PD/front-end electronic/ADC (see Figure 9) by
redesigning the electronic and/or exploiting best performing
components, (ii) tuning the bandwidth of the source, and (iii)
exploiting the isosbestic point of the CENTA spectra, thus
measuring the absorption of the sample also at 370 nm (see
Figure 5).
Indeed, the used LED has a nominal full width at half
maximumat 20mAequal to 15 nm; thus, systemperformance
can be reasonably improved by reducing the bandwidth of the
source. Such can be accomplished by using optical filters or
laser diodes (LD).
Coherent sources such as lasers can lead to problem
related to interference (e.g., speckles). However, an auto-
mated power control of the laser diode [28] and the analysis
of the resulting self-mixing signal can allow us to obtain
further information such as the size of milk particles [29],
hence potentially providing further information about the
milk quality [30].
Moreover, although the absorption peak of the hydro-
lyzed CENTA is at about 405 nm (see Figures 5 and 6),
as shown in Figure 7, the spectral region around 420 nm
reveals a great variation of absorbance; thus, we are currently
investigating the possibility of performing the measure in
such spectral region.
Concluding, the proposed measurement method and the
measuring system are simple, quantitative, sensitive, and easy
to use on the field. Thus, they are useful in delivering rapid
results, where access to laboratory analysis is impractical and
uneconomic or delays are commercially unacceptable.
Appendix
A. Derivation of the Measurement Model
The proposed measurement method is based on the hypoth-
esis that, once the concentration of the AmpC is fixed
([𝐸0] in (1)), the lower the concentration of the 𝛽-lactams
antibiotics in the tested milk sample ([𝐼] in (1)), the higher
the hydrolyzation of CENTA by the AmpC, and thus the
higher the variation of the absorption spectrumof the sample.
Hence, the method investigates the concentration of the
hydrolyzed CENTA [𝐶HC].
According to Beer-Lambert’s law, the attenuation of
a monochromatic and collimated light beam of irradi-
ance 𝐼0 traversing a semi-infinite slab of purely absorbing
medium composed of𝑁 chromophores—the light-absorbing
species—is [31]
𝐴 (𝜆) def= log10 [ 𝐼0 (𝜆)𝐼𝑇 (𝜆)] = 𝑑 ⋅ 𝜇𝑎 (𝜆)
= 𝑑 ⋅
𝑁
∑
𝑖=1
𝜖𝑖 (𝜆) ⋅ [𝐶𝑖] ,
(A.1)
where 𝐴 is the optical absorbance (quantity of dimension
one historically referred to as OD (Optical Density)), 𝐼𝑇 is
the irradiance of the beam exiting the slab (transmitted), 𝜇𝑎
is the (overall) absorption coefficient, 𝑑 is the thickness of
the slab (optical path length), 𝜆 is the wavelength, and [𝐶𝑖]
and 𝜖𝑖 are the concentration and the extinction coefficient of
the 𝑖th-chromophore. To take into account scattering, (A.1) is
usually modified as follows [32]:
𝐴 (𝜆) = 𝜇𝑎 (𝜆) ⋅ 𝑑 ⋅ DPF + 𝐺, (A.2)
where the differential pathlength factor (DPF) takes into
account the extended pathlength due to scattering and 𝐺
represents the losses due to scattering.
In our system, supposing that 𝐴CENTA(𝜆) is the (steady-
state) overall optical absorbance of the milk sample after the
addition of CENTA—time interval [𝑡CENTA + Δ 𝑡, 𝑡AmpC) in
Figure 3—from (A.1) and (A.2) the overall optical absorbance
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𝐴AmpC of the milk sample after the addition of AmpC can be
written as follows:
𝐴AmpC (𝜆, 𝑡) = 𝐴CENTA (𝜆) + ⋅ ⋅ ⋅
+ [𝐶HC] (𝑡) [𝜖HC (𝜆) − 𝜖󸀠 (𝜆)] ⋅ 𝑑
⋅ DPF,
(A.3)
where 𝜖HC is the extinction coefficient of the hydrolyzed
CENTA and 𝜖󸀠 takes into account the extinction coefficients
of the reactants consumed to produce hydrolyzed CENTA.
The digitized output voltage 𝑉PD(𝑛) of the front-end
electronic is proportional to the current photogenerated by
PD. Hence, omitting noises, the signal𝑉PD(𝑛) depends on the
optical power 𝑃𝑇 impinging on the photodiode active area:
𝑉PD = 𝑠TOT ⋅ 𝑃𝑇 + 𝑉offset = 𝑘 ⋅ 𝑃010𝐴 + 𝑉offset, (A.4)
where 𝑠TOT is the product of the sensitivities of the photo-
diode and front-end electronic, 𝑉offset takes into account the
offsets, and 𝑘 is determined by the sensitivity 𝑠TOT and the
geometry of the system. Indeed, the irradiance 𝐼0 is related to
the power 𝑃0 emitted by the LED and the power 𝑃𝑇 is related
to the irradiance 𝐼𝑇. Then, to take into account the offset
voltage 𝑉offset, before starting the measurement, the cuvette
was replaced with a beam blocker, thus obtaining
𝑉Dark = 125 ⋅
25
∑
𝑛=1
𝑉PD (𝑛) . (A.5)
Hence, supposing that 𝑃0, 𝑠TOT, and the geometry of the
measuring system do not change during the time interval
[𝑡0, 𝑡Meas], according to (A.1) and (A.3), the Γ function,
defined as
Γ (𝑛 − 𝑛4) | 𝑛 ∈ [𝑛4, 𝑛TOT] = log10𝑉CENTA − 𝑉Dark𝑉PD (𝑛) − 𝑉Dark
≈ [𝐶HC] (𝑡) [𝜖HC (𝜆) − 𝜖󸀠 (𝜆)] ⋅ 𝑑
⋅ DPF,
(A.6)
is proportional to the hydrolyzed CENTA concentration
[𝐶HC](𝑡). Then, since the final settled hydrolyzed CENTA
concentration [𝐶HC](𝑡 → ∞) is determined by the 𝛽-lactams
antibiotic concentration [𝐶𝛽] ([𝐼]), according to (1) the
proposed measurement model estimates the final or steady-
state pseudo-absorbance Γ∞ by interpolating the Γ function
with
Γ (𝑖) = Γ∞ − 𝛽 ⋅ 𝑒−𝛼(𝑖+𝑖𝑥), (A.7)
where, as described in Section 2.3, 𝑖 is the independent
variable, Γ(𝑖) is the dependent variable, and Γ∞, 𝛽, 𝛼, and 𝑖𝑥
are the parameters.
Note that in our method the CENTA concentration is
about three orders of magnitude higher than the AmpC
concentration (see Table 3); thus, the substrate concentration
in (1) is almost constant ([𝑆](𝑡) ≈ [𝑆0]).
Finally, from (1) the final or steady-state concentration of
the hydrolyzed CENTA [𝐶HC] can be written as follows:
[𝐶HC] (𝑡 󳨀→ ∞) ≈ 𝑎
󸀠
𝑏󸀠 + [𝐶𝛽]
. (A.8)
Hence, from (A.6), the antibiotic concentration [𝐶𝛽] can be
estimated from the final or steady-state pseudo-absorbance
Γ∞:
[𝐶𝛽] = 𝑎Γ∞ − 𝑏, (A.9)
where 𝑎 and 𝑏 are the constants of the calibration function
that will be obtained experimentally.
Note that, according to (A.9), the proposed method is
based on Γ∞, thus substantially resulting in an end-point
method.
B. 𝛽-Lactamase Detection
As described in Section 2.2, the proposed measurement
method is based on the additions of known amounts of
CENTA ([𝑆0] in eq. (1)) and, subsequently, AmpC ([𝐸0]).
According to eq. (A.1) and as shown in Figure 6, the first
addition of CENTA is expected to give rise to a known and
fixed variation of the absorbance of the sample under test
Δ𝐴CENTA−0 (curves 󳶋 and I). In other words, according to
eq. (A.1):
𝐴CENTA−0 (𝜆) − 𝐴Milk (𝜆) = Δ𝐴CENTA−0 (𝜆)
= [𝑆0] ⋅ 𝜖𝐶 (𝜆) ⋅ 𝑑 ⋅ DPF,
(B.1)
where 𝐴Milk is the absorption of the sample before
the addition of CENTA, 𝐴CENTA−0 is the expected—no𝛽-lactamases—absorption of the sample after the addition of
CENTA and 𝜖𝐶 is the extinction coefficient of the CENTA.
Thus, if at the addition of CENTA some AmpC is already
present in the sample, the absorption variation in the time
interval [𝑡CENTA + Δ𝑡, 𝑡AmpC),
Δ𝐴CENTA (𝜆, 𝑡) = 𝐴 (𝜆, 𝑡) − 𝐴Milk (𝜆) , (B.2)
will be different from Δ𝐴CENTA−0(𝜆) (i.e., curves 󳵻, ⊳, +, ⊲,◻, ×, ⬦ in Figure 6). In particular, according to (A.3), the
difference
Δ𝐴CENTA (𝜆, 𝑡) − Δ𝐴CENTA−0 (𝜆)
= [𝐶HC] (𝑡) [𝜖HC (𝜆) − 𝜖󸀠 (𝜆)] ⋅ 𝑑 ⋅ DPF
(B.3)
is proportional to the concentration of the (eventually)
hydrolyzed CENTA [𝐶HC] and thus to the 𝛽-lactamase
(eventually) illegally added to themilk.Hence, supposing that
Γ0 is
Γ0 = log10 𝑉Milk − 𝑉Dark𝑉CENTA − 𝑉Dark , (B.4)
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recorded during calibration (in the absence of 𝛽-lactamases
in milk), in analogy to (A.6),
Γ (𝑛 − 𝑛2) | 𝑛 ∈ [𝑛2, 𝑛3] = log10 𝑉Milk − 𝑉Dark𝑉PD (𝑛) − 𝑉Dark − Γ0
≈ [𝐶HC] (𝑡) [𝜖HC (𝜆) − 𝜖󸀠 (𝜆)] ⋅ 𝑑 ⋅ DPF
(B.5)
is proportional to the concentration of the hydrolyzed
CENTA [𝐶HC]. As a result, the system is able to reveal
eventual 𝛽-lactamases illegally added to milk. The higher
the concentration of the 𝛽-lactamases illegally added to
milk, the higher the variation of the absorption spectra
Δ𝐴CENTA(𝜆, 𝑡) − Δ𝐴CENTA−0(𝜆), resulting in a quantitative
method. The achievable detection limit of 𝛽-lactamases rea-
sonably depends on several parameters. However, as shown
in Figure 7, few 𝜇M of AmpC can be reasonably detected.
Indeed, according to Figure 7, the addition of CENTA is
expected to produce a negligible variation of the absorption
at 420 nm (from curve 󳶋, to curve I). On the contrary, an
AmpC (Escherichia coli K12 AmpC 𝛽-lactamase) concentra-
tion equal to 13.85 𝜇M gives rise to a steady-state variation
greater than 0.4 OD (from curve 󳶋, to curve 󳵻).
Note also that in our method the AmpC concentration is
in excess in comparison to the concentration of the 𝛽-lactam;
thus, the analysis of Γ(𝑛 − 𝑛4) | 𝑛 ∈ [𝑛4, 𝑛TOT] is expected
to be able to reveal the presence of 𝛽-lactams even if some
𝛽-lactamases have been illegally added to milk. Nevertheless,
the presence of 𝛽-lactamases illegally added to the milk
sample results in a different [𝐸0] (see (1)); hence, 𝑎 and 𝑏
constants of the calibration function are in general no longer
valid; thus, the analysis provided by the developedmeasuring
system will be qualitative only.
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